Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Metastatic Carcinoid Expressing Aquaporin-4
Figueroa, Michelle, Guo, Yong , Tselis, Alexandros, Pittock, Sean J. , Lennon, Vanda A. , Lucchinetti, Claudia F. , Lisak, Robert P. , Pittock, S J , Guo, Yong

JAMA Neurology | April 14, 2014 | Volume: 71 | Issue: 4 | Pages: 495

10.1001/jamaneurol.2013.6331 | PMID 24733266 Get It

Paroxysmal Sympathetic Hyperactivity after Acquired Brain Injury: Consensus on Conceptual Definition, Nomenclature, and Diagnostic Criteria
Perkes, Iain , Fernández-Ortega, J.F. , Dolce, G, Hendricks, Henk T., Group, for the Consensus Working, Baguley, Ian James , Rabinstein, Alejandro A. , Group, for the Consensus Working

Journal of Neurotrauma | April 14, 2014 | Volume: 31 | Issue: 17 | Pages: 1515-1520

10.1089/neu.2013.3301 | PMID 24731076 Get It

Incidence of chronic lymphocytic leukemia and high‐count monoclonal B‐cell lymphocytosis using the 2008 guidelines
Call, Timothy G. , Hanson, Curtis A. , Achenbach, Sara J., Cerhan, James R. , Rabe, Kari G. , Vachon, Celine M. , Hallberg, Emily J., Norman, Aaron D. , Kay, Neil E. , Zent, Clive S. , Ding, Wei , Vachon, Celine M. , Shanafelt, Tait D. , Slager, Susan L. , Chaffee, Kari G. , Cerhan, James R

Cancer | April 14, 2014 | Volume: 120 | Issue: 13 | Pages: 2000-2005

10.1002/cncr.28690 | PMID 24711224 Get It

BACKGROUNDThe 1996 National Cancer Institute Working Group (NCI‐WG 96) guidelines classified disease in individuals who had a B‐cell clone with chronic lymphocytic leukemia (CLL) immunophenotype as CLL if their absolute lymphocyte count was ≥5 × 109/L. The 2008 International Workshop on CLL guidelines (IWCLL 2008) classified disease as CLL if the absolute B‐cell count was ≥5 × 109/L or as monoclonal B‐cell lymphocytosis (MBL) if the absolute B‐cell count was <5 × 109/L. The objective of the current study of Olmsted County, Minnesota, was to assess the effects of these changes on incidence rates and presentation from 2000 to 2010.METHODSUsing diagnostic indices available through the Rochester Epidemiology Project and the Mayo CLL database, the authors identified all patients with newly diagnosed CLL and high‐count MBL from 2000 to 2010. Age‐specific and sex‐specific incidence rates were determined.RESULTSAccording to NCI‐WG 96 criteria, there were 115 patients with CLL and 8 patients with MBL during the period studied. Using the IWCLL 2008 classification, there were 79 patients with CLL and 40 patients with MBL. Rai stage distribution (low risk, intermediate risk, and high risk) using NCI‐WG 96 criteria was 60.9%, 33.9%, and 5.2%, respectively, compared with 43%, 49.4%, and 7.6%, respectively, using IWCLL 2008 criteria. The age‐adjusted and sex‐adjusted incidence rates (per 100,000) for CLL and MBL were 10.0 and 0.66, respectively, using NCI‐WG 96 criteria versus 6.8 and 3.5, respectively, using IWCLL 2008 criteria. The median time to treatment according to NCI‐WG 96 criteria was 9.2 years versus 6.5 years with IWCLL 2008 criteria.CONCLUSIONSUse of the IWCLL 2008 guidelines reduced the incidence of CLL, altered the distribution of initial Rai stage at diagnosis, and shortened the median time to treatment. Cancer 2014;120:2000–2005. © 2014 American Cancer Society.
Infectious disease testing for cellular therapy
Adams, Roberta H.

Pediatric Blood & Cancer | April 14, 2014 | Volume: 61 | Issue: 8 | Pages: 1339-1340

10.1002/pbc.25052 | PMID 24729473 Get It

Analysis of flow changes in side branches jailed by flow diverters in rabbit models
Raschi, Marcelo , Mut, Fernando , Ding, Yong‐Hond, Kadirvel, Ramanathan , Kallmes, David F. , Cebral, Juan R. , Dai, Daying

International Journal for Numerical Methods in Biomedical Engineering | April 14, 2014 | Volume: 30 | Issue: 10 | Pages: 988-999

10.1002/cnm.2640 | PMID 24729467 Get It

SUMMARYUnderstanding the flow alteration in side branches during flow diversion treatment of cerebral aneurysms is important to prevent ischemic complications and improve device designs. Flow diverters were placed in the aorta of four rabbits crossing the origin of side arteries. Subject‐specific computational models were constructed from 3D angiographies and Doppler ultrasounds (DUSs). Flow simulations were run before and after virtually deploying the flow diverters, assuming distal resistances remained unchanged after treatment. All jailed arteries remained patent angiographically 8 weeks after treatment. The computational models estimated decreases compared to pretreatment in the mean flow rates between 2% and 20% and in peak flow rates between 5% and 36%. The major changes were observed during systole. Flow patterns did not exhibit recirculation zones before treatment. Implantation of the flow diverters altered the flow structure only locally near the device wires. No major recirculation regions were created or destroyed. Flow diverters seem safe with respect to perforator or side branch occlusion. Relatively small changes in flow rates through jailed arteries are expected, even for moderate to large degrees of coverage of their origins. These results seem consistent with previous clinical experiences where no or very few complications related to perforator occlusion have been reported.Copyright © 2014 John Wiley & Sons, Ltd.
ATM Increases Activation-Induced Cytidine Deaminase Activity at Downstream S Regions during Class-Switch Recombination
Khair, Lyne , Guikema, Jeroen E. J. , Linehan, Erin K., Ucher, Anna J., Leus, Niek G.J., Ogilvie, Colin, Schrader, Carol E. , Stavnezer, Janet, Lou, Zhenkun

The Journal of Immunology | April 12, 2014 | Volume: 192 | Issue: 10 | Pages: 4887-4896

10.4049/jimmunol.1303481 | PMID 24729610 Get It

Abstract Activation-induced cytidine deaminase (AID) initiates Ab class-switch recombination (CSR) in activated B cells resulting in exchanging the IgH C region and improved Ab effector function. During CSR, AID instigates DNA double-strand break (DSB) formation in switch (S) regions located upstream of C region genes. DSBs are necessary for CSR, but improper regulation of DSBs can lead to chromosomal translocations that can result in B cell lymphoma. The protein kinase ataxia telangiectasia mutated (ATM) is an important proximal regulator of the DNA damage response (DDR), and translocations involving S regions are increased in its absence. ATM phosphorylates H2AX, which recruits other DNA damage response (DDR) proteins, including mediator of DNA damage checkpoint 1 (Mdc1) and p53 binding protein 1 (53BP1), to sites of DNA damage. As these DDR proteins all function to promote repair and recombination of DSBs during CSR, we examined whether mouse splenic B cells deficient in these proteins would show alterations in S region DSBs when undergoing CSR. We find that in atm−/− cells Sμ DSBs are increased, whereas DSBs in downstream Sγ regions are decreased. We also find that mutations in the unrearranged Sγ3 segment are reduced in atm−/− cells. Our data suggest that ATM increases AID targeting and activity at downstream acceptor S regions during CSR and that in atm−/− cells Sμ DSBs accumulate as they lack a recombination partner.
Association Study of the let-7 miRNA-Complementary Site Variant in the 3′ Untranslated Region of theKRASGene in Stage III Colon Cancer (NCCTG N0147 Clinical Trial)
Sha, Dan , Shi, Qian , Sargent, Daniel J. , Diasio, Robert B. , Lee, Adam M. , Alberts, Steven R. , Sinicrope, Frank A. , Sargent, Daniel J , Shi, Qian

Clinical Cancer Research | April 12, 2014 | Volume: 20 | Issue: 12 | Pages: 3319-3327

10.1158/1078-0432.ccr-14-0069 | PMID 24727325 Get It

AbstractPurpose: A let-7 microRNA-complementary site (LCS6) polymorphism in the 3′ untranslated region of the KRAS gene has been shown to disrupt let-7 binding and upregulate KRAS expression. We evaluated the LCS6 genotype and its association with KRAS mutation status, clinicopathologic features, and disease-free survival (DFS) in patients with stage III colon cancer who enrolled in a phase III clinical trial (NCCTG N0147).Experimental Design: The LCS6 genotype was assayed by real-time PCR in DNA extracted from whole blood (n = 2,834) and compared with paired tumor tissue (n = 977). χ2 and two-sample t tests were used to compare baseline factors and KRAS mutation status between patients defined by LCS6 variant status. Log-rank tests and multivariate Cox models assessed associations between LCS6 status and DFS, respectively.Results: We identified 432 (15.2%) blood samples and 143 (14.6%) tumor samples heterozygous or homozygous for the LCS6 G-allele, and 2,402 of 2,834 (84.8%) blood samples and 834 of 977 (85.4%) tumor samples homozygous for the LCS6 T-allele. Genotype results were highly concordant (99.8%) in cases with paired blood and tumor tissue (n = 977). G-allele carriers were significantly more frequent in Caucasians versus other races (χ2 test, P &lt; 0.0001). The LCS6 genotype was not associated with KRAS mutation status, clinicopathologic features (all P &gt; 0.2), or DFS (log-rank P = 0.49; HR, 0.929; 95% confidence interval, 0.76–1.14), even after combining LCS6 genotype with KRAS mutation status.Conclusions: In the largest association study investigating the LCS6 polymorphism in colon cancers, the germline LCS6 genotype was not associated with KRAS mutation status or with clinical outcome in patients with stage III tumors. Clin Cancer Res; 20(12); 3319–27. ©2014 AACR.
Pattern of CD14+ Follicular Dendritic Cells and PD1+ T Cells Independently Predicts Time to Transformation in Follicular Lymphoma
Smeltzer, Jacob P., Jones, Jason M. , Ziesmer, Steven C., Grote, Deanna M., Xiu, Bing, Ristow, Kay M., Nowakowski, Grzegorz S. , Feldman, Andrew L. , Cerhan, James R. , Novak, Anne J. , Ansell, Stephen M. , Yang, Zhi Zhang , Feldman, Andrew L , Cerhan, James R

Clinical Cancer Research | April 12, 2014 | Volume: 20 | Issue: 11 | Pages: 2862-2872

10.1158/1078-0432.ccr-13-2367 | PMID 24727328 Get It

Abstract Purpose: Transformation of follicular lymphoma is a critical event associated with a poor prognosis. The role of the tumor microenvironment in previous transformation studies has yielded conflicting results. Experimental Design: To define cell subtypes associated with transformation, we examined tissue specimens at diagnosis from patients with follicular lymphoma that later transformed and, using immunohistochemistry (IHC), stained for CD68, CD11c, CD21, CXCL13, FOXP3, PD1, and CD14. Cell content and the pattern of expression were evaluated. Those identified as significantly associated with time to transformation (TTT) and overall survival (OS) were further characterized by flow cytometry and multicolor IHC. Results: Of note, 58 patients were analyzed with median TTT of 4.7 years. The pattern of PD1+ and CD14+ cells rather than the quantity of cells was predictive of clinical outcomes. On multivariate analysis, including the follicular lymphoma international prognostic index score, CD14+ cells localized in the follicle were associated with a shorter TTT (HR, 3.0; P = 0.004). PD1+ cells with diffuse staining were associated with a shorter TTT (HR, 1.9; P = 0.045) and inferior OS (HR, 2.5; P = 0.012). Multicolor IHC and flow cytometry identified CD14+ cells as follicular dendritic cells (FDC), whereas PD1+ cells represented two separate populations, TFH and exhausted T cells. Conclusion: These results identify the presence of PD1+ T cells and CD14+ FDC as independent predictors of transformation in follicular lymphoma. Clin Cancer Res; 20(11); 2862–72. ©2014 AACR.
Tumor Hypomethylation at 6p21.3 Associates with Longer Time to Recurrence of High-Grade Serous Epithelial Ovarian Cancer
Wang, Chen , Cicek, Mine , Charbonneau, Bridget, Kalli, Kimberly R., Armasu, Sebastian M. , Konecny, Gottfried E. , Winterhoff, Boris , Fan, Jian-Bing, Bibikova, Marina, Chien, Jeremy , Shridhar, Viji , Block, Matthew S. , Hartmann, Lynn C. , Visscher, Daniel W., Cunningham, Julie M. , Knutson, Keith L. , Goode, Ellen L. , Cicek, Mine S., Larson, Melissa C. , Knutson, Keith L. , Fridley, Brooke L. , Chien, Jeremey , Wang, Chen

Cancer Research | April 12, 2014 | Volume: 74 | Issue: 11 | Pages: 3084-3091

10.1158/0008-5472.can-13-3198 | PMID 24728075 Get It

Abstract To reveal biologic mechanisms underlying clinical outcome of high-grade serous (HGS) epithelial ovarian carcinomas (EOC), we evaluated the association between tumor epigenetic changes and time to recurrence (TTR). We assessed methylation at approximately 450,000 genome-wide CpGs in tumors of 337 Mayo Clinic (Rochester, MN) patients. Semi-supervised clustering of discovery (n = 168) and validation (n = 169) sets was used to determine clinically relevant methylation classes. Clustering identified two methylation classes based on 60 informative CpGs, which differed in TTR in the validation set [R vs. L class, P = 2.9 × 10−3, HR = 0.52; 95% confidence interval (CI), 0.34–0.80]. Follow-up analyses considered genome-wide tumor mRNA expression (n = 104) and CD8 T-cell infiltration (n = 89) in patient subsets. Hypomethylation of CpGs located in 6p21.3 in the R class associated with cis upregulation of genes enriched in immune response processes (TAP1, PSMB8, PSMB9, HLA-DQB1, HLA-DQB2, HLA-DMA, and HLA-DOA), increased CD8 T-cell tumor infiltration (P = 7.6 × 10−5), and trans-regulation of genes in immune-related pathways (P = 1.6 × 10−32). This is the most comprehensive assessment of clinical outcomes with regard to epithelial ovarian carcinoma tumor methylation to date. Collectively, these results suggest that an epigenetically mediated immune response is a predictor of recurrence and, possibly, treatment response for HGS EOC. Cancer Res; 74(11); 3084–91. ©2014 AACR.
Comment: Awareness in partial seizures—Implications for patients and therapies
Crepeau, Amy Z. , Cascino, Gregory D.

Neurology | April 12, 2014 | Volume: 82 | Issue: 19 | Pages: 1742-1742

10.1212/wnl.0000000000000418 | PMID 24727308 Get It